A pilot study presented at EBMT 2025 shows adoptive cell therapy using memory T lymphocytes effectively treats infections in ...

1 This molecular program gives T cells the ability to remember threats that they’ve seen before and mount an immune response for a long period of time—key assets for a CAR T cell training to fight a ...

Chimeric antigen receptor (CAR) T cell therapy is an immunotherapy. It uses a patient’s own immune system to fight certain blood cancers. Normal T cells can “hook” onto cancer cells and kill them, but ...

Fighting cancer is exhausting for T cells. Hostile tumor microenvironments can drain their mitochondrial activity, leading to a condition known as T cell ... T cells for adoptive transfer.

However, functional analysis and in vivo transfer of MHC multimer-stained cells is hampered by the persistence of T-cell receptor (TCR)–MHC interactions and subsequently induced signaling events.

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors - a smart fighter that destroys cancer cells for days without tiring.